Article

Making plans for ASCO 2011

Just received my invitation to register for the American Society of Clinical Oncology annual meeting this year. This is the "big one," the meeting where more than 30,000 oncologists, researchers, industry representatives (and journalists like us) converge on Chicago to learn the latest research and trends in cancer care. This year the theme is "Patients. Pathways. Progress." The ASCO website states: This year, we expect educational and scientific sessions will have an extensive focus on patient and survivor care, including topics like cancer-related complications, quality-of-life management and end-of-life care. Sounds promising.The meeting, which will be held June 3-7, barely makes it into our Summer issue, which means you'll get up-to-date information from our Breaking News section. We'll be reporting on the "hot topics" in the magazine, but if you sign up for our e-newsletter CURExtra you'll receive additional news and blogs from the conference. You can read our ASCO coverage from 2010 here. So, what are you hoping to hear about from the meeting? Let us know and we'll keep an ear out for you!

Related Videos
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Dr. Tycel Phillips is an Associate Professor in the Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, at City of Hope in Duarte, California.
Image of Dr. Salani.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Suneel Kamath is an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, in Ohio.